MedTech

At present, there are three approved treatments for scleroderma, including bosentan, nintedanib, and tocilizumab

The launch integrates advanced technology in healthcare, ensuring better outcomes for patients

The global dual chamber leadless pacemaker market is poised to grow at a CAGR of 8.95 per cent from $185.9 million in 2023 to $438…

The research compares early outcomes of the new-generation Myval THV series with contemporary (Sapien and Evolut) THV series in…

Reportedly, Canon has a comprehensive portfolio of advanced medical products and solutions from diagnostic imaging systems and…

Funds raised in its first equity investment will be used to launch telemedicine and AI-enabled eye-screening devices

The procedure is known for its safety and faster recovery period compared to other methods

The market for neurological devices was valued at $12.5 billion in 2023 and is expected to grow by a CAGR of 4.60 per cent to…

The partnership aims to leverage clinical expertise and insights to drive the development of innovative medical solutions that…

The new technology optimises diagnostic imaging and patient care